@article{ref1,
title="Carbamazepine in the treatment of psychotic and behavioral disorders: A pilot study",
journal="Acta psychiatrica Belgica",
year="1981",
author="de Vogelaer, J.",
volume="81",
number="6",
pages="532-541",
abstract="Administered carbamazepine (CB) to 3 groups of psychiatric patients (aged 17-55 yrs) over 2 wks. 10 received CB, while 10 received placebo. Symptoms (mostly psychotic) of agitation and disruptive behavior, loss of impulse control (e.g., aggressiveness, impulsivity, perversity, suicide attempts, orality, and pseudomania), and extrapyramidal symptoms in Ss with a premorbid active-ambivalent personality pattern, in the absence of clinical and EEG signs of epilepsy, indicated the use of CB. This drug allowed a reduction, sometimes marked, of high doses of neuroleptics, as well as of many indications for Li. (French, Spanish, Italian & Dutch abstracts) (PsycINFO Database Record (c) 2016 APA, all rights reserved)<p />",
language="fr",
issn="0300-8967",
doi="",
url="http://dx.doi.org/"
}